The CRP/ALB ratio is a useful marker not only for predicting survival, but also for monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer who receive palliative chemotherapy. The gene discussed is ALB; the disease is metastatic colorectal cancer.